VOR - Vor Biopharma Inc
14.56
-0.490 -3.365%
Share volume: 464,331
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$15.05
-0.49
-0.03%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 03-20-2025 | 05-14-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | ||||
| Operating expenses | 31.311 M | 33.291 M | 28.107 M | |
| Selling general and admin | 5.963 M | 6.590 M | 13.965 M | |
| Research and development | 25.348 M | 26.701 M | 14.142 M | |
| Total expenses | 31.311 M | 33.291 M | 28.107 M | |
| 6.32% | -15.57% | |||
| Operating income | -31.311 M | -33.291 M | -28.107 M | |
| Ebit | -31.311 M | -33.291 M | -814.415 M | |
| Pretax income | -30.712 M | -32.486 M | -812.684 M | |
| 5.78% | 2,401.64% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -30.712 M | -32.486 M | -812.684 M | |
| -5.78% | -2,401.64% |